Access free, up-to-date clinical references for comprehensive information on assessing multiple sclerosis at Healio. Our content provides valuable insights for physicians.

Medical experts discuss the failure of evobrutinib to meet its primary endpoint in phase 3 trials, review the primary outcomes of the phase 2B study of tolebrutinib in relapsing multiple sclerosis ...

FSD Pharma Inc. (NASDAQ: HUGE) has dosed the first subjects in its first clinical trial assessing the New Chemical Entity (NCE) Lucid-21-302, or Lucid-MS, targetting multiple sclerosis.

But when this twitching is from multiple sclerosis (MS), this facial twitching may spread. It might go down your cheek to your mouth or jawline. And it happens more often.

Clinical Features of Multiple Sclerosis. Perez CA, Smith A, Nelson F. In: Multiple Sclerosis: A Practical Manual for Hospital and Outpatient Care. Cambridge University Press; 2021:21-36.

A total of 234 COVID-19 cases were identified among multiple sclerosis patients, of which 13.2% were hospitalized and 2.1% (5 patients) died due to the infection.

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer anti-inflammatory benefits in multiple sclerosis.

Your mental health and multiple sclerosis (MS) are most likely interconnected. Learn how the condition changes your brain.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

MULTIPLE SCLEROSIS TREATMENTS; Generic Brand Strength Form Adult Dose; ORAL FORMS: cladribine: Mavenclad: 10mg: tabs: Give 3.5mg/kg cumulative dose divided into 2 yearly treatment courses (1.75mg ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing ...